GAO’s reports and testimonies give Congress, federal agencies, and the public timely, fact-based, non-partisan information that can improve government operations and save taxpayers billions of dollars.
The Office of National Drug Control Policy (ONDCP) coordinates the nation's drug control policy. ONDCP's responsibilities include tracking and publicizing information about federal grants that fund drug control activities, such as prevention and treatment.
While COVID-19 cases have declined in recent months, the U.S. is still experiencing serious economic and public health repercussions due to the pandemic. In our 7th comprehensive report, we found more ways to improve federal programs related to the pandemic and other future emergencies.
Each year, we make more than 1,000 recommendations to help improve the federal government. We alert department heads to the recommendations where they can save the most money, address issues on our High Risk List, or significantly improve government operations.
We make more than 1,000 recommendations annually to help improve government. We alert department heads to the recommendations that can save the most money, address issues on our High Risk List, or significantly improve their operations.
Federal agencies are increasingly using cloud computing services. Cloud computing offers benefits but also poses cybersecurity risks. OMB requires agencies to use the Federal Risk and Authorization Management Program to authorize their use of cloud services.
Certain building materials used before 1981 are more likely to contain asbestos. To facilitate oversight, the General Services Administration keeps a database of information on asbestos in its buildings.
What GAO Found The 23 civilian Chief Financial Officer (CFO) Act agencies reported various ways of considering and using telework as a space-planning tool, by, for example, implementing desk-sharing for employees who telework in order to relinquish leased space, or increasing the number of staff working...
Laboratories conduct research on hazardous pathogens—such as Ebola virus or anthrax bacteria—in more than 200 labs in the United States. Safety lapses have occurred at some of these labs, raising concerns about whether oversight is effective.